While 2015 might not have been the year of the blockbuster Alzheimer’s drug, it did lay a few more paving stones on the road to understanding the disease.

Federal funding boosts, new-generation...

Field of Interest: Geriatrics

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness